Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 480

1.

Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma.

Arroyo VM, Lupo PJ, Scheurer ME, Rednam SP, Murray J, Okcu MF, Chintagumpala MM, Brown AL.

Cancer Epidemiol. 2019 Jan 28;59:71-74. doi: 10.1016/j.canep.2019.01.011. [Epub ahead of print]

PMID:
30703618
2.

Impact of air pollution on low birth weight in Spain: An approach to a National Level Study.

Arroyo V, Díaz J, Salvador P, Linares C.

Environ Res. 2019 Apr;171:69-79. doi: 10.1016/j.envres.2019.01.030. Epub 2019 Jan 14.

PMID:
30660920
3.

Premature births in Spain: Measuring the impact of air pollution using time series analyses.

Arroyo V, Linares C, Díaz J.

Sci Total Environ. 2019 Apr 10;660:105-114. doi: 10.1016/j.scitotenv.2018.12.470. Epub 2019 Jan 3.

PMID:
30639707
4.

Orchestration of Tryptophan-Kynurenine pathway, acute decompensation and acute-on-chronic liver failure in cirrhosis.

Clària J, Moreau R, Fenaille F, Amorós A, Junot C, Gronbaek H, Coenraad MJ, Pruvost A, Ghettas A, Chu-Van E, López-Vicario C, Oettl K, Caraceni P, Alessandria C, Trebicka J, Pavesi M, Deulofeu C, Albillos A, Gustot T, Welzel TM, Fernández J, Stauber RE, Saliba F, Butin N, Colsch B, Moreno C, Durand F, Nevens F, Bañares R, Benten D, Ginès P, Gerbes A, Jalan R, Angeli P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL Clif Consortium Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif).

Hepatology. 2018 Dec 6. doi: 10.1002/hep.30363. [Epub ahead of print]

PMID:
30521097
5.

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.

Fernández J, Prado V, Trebicka J, Amoros A, Gustot T, Wiest R, Deulofeu C, Garcia E, Acevedo J, Fuhrmann V, Durand F, Sánchez C, Papp M, Caraceni P, Vargas V, Bañares R, Piano S, Janicko M, Albillos A, Alessandria C, Soriano G, Welzel TM, Laleman W, Gerbes A, De Gottardi A, Merli M, Coenraad M, Saliba F, Pavesi M, Jalan R, Ginès P, Angeli P, Arroyo V; European Foundation for the Study of Chronic Liver Failure (EF-Clif).

J Hepatol. 2019 Mar;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027. Epub 2018 Nov 2.

PMID:
30391380
6.

DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study.

Lupo PJ, Brown AL, Arroyo VM, Kamdar KY, Belmont JW, Scheurer ME, Leisenring WM, Monica Gramatges M, Fatih Okcu M, Yasui Y, Oeffinger KC, Robison LL, Armstrong GT, Bhatia S.

Genes Chromosomes Cancer. 2019 Jan;58(1):52-59. doi: 10.1002/gcc.22701. Epub 2018 Dec 4.

PMID:
30382603
7.

Dynamic Prognostication in Critically Ill Cirrhotic Patients With Multiorgan Failure in ICUs in Europe and North America: A Multicenter Analysis.

Karvellas CJ, Garcia-Lopez E, Fernandez J, Saliba F, Sy E, Jalan R, Pavesi M, Gustot T, Ronco JJ, Arroyo V; Chronic Liver Failure Consortium and European Foundation for the Study of Chronic Liver Failure.

Crit Care Med. 2018 Nov;46(11):1783-1791. doi: 10.1097/CCM.0000000000003369.

PMID:
30106759
8.

Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis.

Alcaraz-Quiles J, Casulleras M, Oettl K, Titos E, Flores-Costa R, Duran-Güell M, López-Vicario C, Pavesi M, Stauber RE, Arroyo V, Clària J.

Hepatology. 2018 Nov;68(5):1937-1952. doi: 10.1002/hep.30135. Epub 2018 Oct 13.

PMID:
30070728
9.

Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?

Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, Szabo G, Tandon P, Olson J, Karvellas C, Gustot T, Lai JC, Wong F.

Hepatology. 2018 Oct;68(4):1621-1632. doi: 10.1002/hep.30056. Epub 2018 Sep 22. Review.

PMID:
29689120
10.

The use of human albumin in patients with cirrhosis: a European survey.

Caraceni P, Pavesi M, Baldassarre M, Bernardi M, Arroyo V.

Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):625-632. doi: 10.1080/17474124.2018.1460203. Epub 2018 Apr 4.

PMID:
29611452
11.

The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis.

Sersté T, Cornillie A, Njimi H, Pavesi M, Arroyo V, Putignano A, Weichselbaum L, Deltenre P, Degré D, Trépo E, Moreno C, Gustot T.

J Hepatol. 2018 Aug;69(2):318-324. doi: 10.1016/j.jhep.2018.02.022. Epub 2018 Mar 8.

PMID:
29524528
12.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.

Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Hüsing-Kabar A, Solà E, Gerbes A, Bernardi M, Alessandria C, Scheiner B, Tonon M, Maschmeier M, Solè C, Trebicka J, Gustot T, Nevens F, Arroyo V, Gines P, Angeli P; EASL CLIF Consortium, European Foundation for the Study of Chronic Liver Failure (EF Clif).

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.

PMID:
29391267
13.

Acute-on-Chronic Liver Failure, Human Serum Albumin, and Immune Modulation: The Beginning of an Exciting Adventure.

Arroyo V, Clària J.

Clin Gastroenterol Hepatol. 2018 May;16(5):633-636. doi: 10.1016/j.cgh.2017.12.008. Epub 2017 Dec 12. No abstract available.

PMID:
29246698
14.

Cell death markers in patients with cirrhosis and acute decompensation.

Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Mookerjee R, Zheng YB, Gronbaek H, Gerbes AL, Sola E, Caraceni P, Moreau R, Gines P, Arroyo V, Jalan R.

Hepatology. 2018 Mar;67(3):989-1002. doi: 10.1002/hep.29581. Epub 2018 Jan 24.

PMID:
29023872
15.

Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.

Fernández J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C, Reverter E, Martínez J, Saliba F, Jalan R, Welzel T, Pavesi M, Hernández-Tejero M, Ginès P, Arroyo V; European Foundation for the Study of Chronic Liver Failure.

Gut. 2018 Oct;67(10):1870-1880. doi: 10.1136/gutjnl-2017-314240. Epub 2017 Aug 28.

PMID:
28847867
16.

Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis.

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Hüsing-Kabar A, Wilms C, Maschmeier M, Kabar I, Torner J, Pavesi M, Arroyo V, Banares R, Schmidt HHJ.

Crit Care Med. 2017 Oct;45(10):1616-1624. doi: 10.1097/CCM.0000000000002562.

17.

Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.

Markwardt D, Holdt L, Steib C, Benesic A, Bendtsen F, Bernardi M, Moreau R, Teupser D, Wendon J, Nevens F, Trebicka J, Garcia E, Pavesi M, Arroyo V, Gerbes AL.

Hepatology. 2017 Oct;66(4):1232-1241. doi: 10.1002/hep.29290. Epub 2017 Aug 26.

PMID:
28545169
18.

Response to the clinical course and short-term mortality of cirrhotic patients with non-spontaneous bacterial peritonitis infections.

Fernández J, Acevedo J, Arroyo V.

Liver Int. 2017 Apr;37(4):623. doi: 10.1111/liv.13283. No abstract available.

PMID:
28371103
19.

Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis.

Kerbert AJ, Schaapman JJ, van der Reijden JJ, Amorós Navarro À, McCormick A, van Hoek B, Arroyo V, Ginès P, Jalan R, Vargas V, Stauber R, Verspaget HW, Coenraad MJ; CANONIC Study Investigators of the EASL-CLIF Consortium.

Eur J Gastroenterol Hepatol. 2017 May;29(5):535-538. doi: 10.1097/MEG.0000000000000834.

PMID:
28350742
20.

Reply.

Gustot T, Fernandez J, Garcia E, Pavesi M, Arroyo V.

Hepatology. 2017 Jul;66(1):294. doi: 10.1002/hep.29110. Epub 2017 May 26. No abstract available.

PMID:
28195338
21.

Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome.

Arroyo V.

Hepatol Int. 2017 May;11(3):242-244. doi: 10.1007/s12072-017-9784-3. Epub 2017 Jan 25. No abstract available.

PMID:
28124314
22.

Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis.

Arroyo V, Moreau R.

J Hepatol. 2017 Feb;66(2):451-453. doi: 10.1016/j.jhep.2016.10.012. Epub 2016 Dec 15. No abstract available.

PMID:
27989380
23.

The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray.

Clària J, Arroyo V, Moreau R.

J Immunol. 2016 Nov 15;197(10):3755-3761. Review.

24.

Effect of Environmental Factors on Low Weight in Non-Premature Births: A Time Series Analysis.

Díaz J, Arroyo V, Ortiz C, Carmona R, Linares C.

PLoS One. 2016 Oct 27;11(10):e0164741. doi: 10.1371/journal.pone.0164741. eCollection 2016.

25.

Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure.

Alcaraz-Quiles J, Titos E, Casulleras M, Pavesi M, López-Vicario C, Rius B, Lopategi A, de Gottardi A, Graziadei I, Gronbaek H, Ginès P, Bernardi M, Arroyo V, Clària J.

Hepatology. 2017 Jan;65(1):202-216. doi: 10.1002/hep.28896. Epub 2016 Nov 28.

PMID:
27775822
26.

LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis.

Odena G, Chen J, Lozano JJ, Altamirano J, Rodrigo-Torres D, Affo S, Morales-Ibanez O, Matsushita H, Zou J, Dumitru R, Caballeria J, Gines P, Arroyo V, You M, Rautou PE, Valla D, Crews F, Seki E, Sancho-Bru P, Bataller R.

Sci Rep. 2016 Oct 18;6:35610. doi: 10.1038/srep35610.

27.

Neuroinflammation in liver disease: sessional talks from ISHEN.

Wright G, Swain M, Annane D, Saliba F, Samuel D, Arroyo V, DeMorrow S, Witt A.

Metab Brain Dis. 2016 Dec;31(6):1339-1354. Epub 2016 Oct 11. Review.

PMID:
27726053
28.

Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue.

Titos E, Rius B, López-Vicario C, Alcaraz-Quiles J, García-Alonso V, Lopategi A, Dalli J, Lozano JJ, Arroyo V, Delgado S, Serhan CN, Clària J.

J Immunol. 2016 Oct 15;197(8):3360-3370. Epub 2016 Sep 19.

29.

Impact of air pollution and temperature on adverse birth outcomes: Madrid, 2001-2009.

Arroyo V, Díaz J, Carmona R, Ortiz C, Linares C.

Environ Pollut. 2016 Nov;218:1154-1161. doi: 10.1016/j.envpol.2016.08.069. Epub 2016 Aug 30.

PMID:
27589893
30.

Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis.

Fernández J, Acevedo J, Prado V, Mercado M, Castro M, Pavesi M, Arteaga M, Sastre L, Juanola A, Ginès P, Arroyo V.

Liver Int. 2017 Mar;37(3):385-395. doi: 10.1111/liv.13239. Epub 2016 Sep 20.

PMID:
27558198
31.

Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.

Clària J, Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, Amorós À, Titos E, Alcaraz-Quiles J, Oettl K, Morales-Ruiz M, Angeli P, Domenicali M, Alessandria C, Gerbes A, Wendon J, Nevens F, Trebicka J, Laleman W, Saliba F, Welzel TM, Albillos A, Gustot T, Benten D, Durand F, Ginès P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-CLIF Consortium and the European Foundation for the Study of Chronic Liver Failure (EF-CLIF).

Hepatology. 2016 Oct;64(4):1249-64. doi: 10.1002/hep.28740. Epub 2016 Aug 25.

PMID:
27483394
32.

Brexit from current guideline recommendations?

Angeli P, Piano S, Arroyo V; International Club of Ascites.

Gut. 2016 Nov;65(11):1919. doi: 10.1136/gutjnl-2016-312422. Epub 2016 Jul 27. No abstract available.

PMID:
27464709
33.

Reply to: "Non-selective beta-blockers for the patients with acute on chronic liver failure".

Jalan R, Pavesi M, Mookerjee RP, Arroyo V.

J Hepatol. 2016 Sep;65(3):646. doi: 10.1016/j.jhep.2016.06.008. Epub 2016 Jun 15. No abstract available.

PMID:
27317484
34.

Acute-on-chronic liver failure in cirrhosis.

Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B.

Nat Rev Dis Primers. 2016 Jun 9;2:16041. doi: 10.1038/nrdp.2016.41. Review.

PMID:
27277335
35.

Acute-on-Chronic Liver Failure: Definition, Diagnosis, and Clinical Characteristics.

Arroyo V, Jalan R.

Semin Liver Dis. 2016 May;36(2):109-16. doi: 10.1055/s-0036-1583202. Epub 2016 May 12. Review.

PMID:
27172351
36.

Acute-on-Chronic Liver Failure: A Distinct Clinical Condition.

Jalan R, Moreau R, Kamath PS, Arroyo V.

Semin Liver Dis. 2016 May;36(2):107-8. doi: 10.1055/s-0036-1583287. Epub 2016 May 12. No abstract available.

PMID:
27172350
37.

Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.

Li H, Chen LY, Zhang NN, Li ST, Zeng B, Pavesi M, Amorós À, Mookerjee RP, Xia Q, Xue F, Ma X, Hua J, Sheng L, Qiu DK, Xie Q, Foster GR, Dusheiko G, Moreau R, Gines P, Arroyo V, Jalan R.

Sci Rep. 2016 May 5;6:25487. doi: 10.1038/srep25487.

38.

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.

Ariza X, Graupera I, Coll M, Solà E, Barreto R, García E, Moreira R, Elia C, Morales-Ruiz M, Llopis M, Huelin P, Solé C, Fabrellas N, Weiss E, Nevens F, Gerbes A, Trebicka J, Saliba F, Fondevila C, Hernández-Gea V, Fernández J, Bernardi M, Arroyo V, Jiménez W, Deulofeu C, Pavesi M, Angeli P, Jalan R, Moreau R, Sancho-Bru P, Ginès P; CANONIC Investigators, EASL CLIF Consortium.

J Hepatol. 2016 Jul;65(1):57-65. doi: 10.1016/j.jhep.2016.03.002. Epub 2016 Mar 14.

PMID:
26988732
39.

Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology.

Bittencourt PL, Terra C, Parise ER, Farias AQ, Arroyo V, Fernandez J, Pereira G, Maubouisson LM, Andrade GM, Costa FG, Codes L, Andrade AR, Mattos AA, Torres A, Couto F, Zyngier I.

Arq Gastroenterol. 2015 Dec;52 Suppl 1:55-72. doi: 10.1590/S0004-28032015000500004. Erratum in: Arq Gastroenterol. 2017 Apr-Jun;54(2):174.

40.

Reply.

Gustot T, Fernandez J, Pavesi M, Arroyo V.

Hepatology. 2016 Sep;64(3):987. doi: 10.1002/hep.28538. Epub 2016 Apr 15. No abstract available.

PMID:
26950184
41.

Reply to "Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers matters".

Jalan R, Mookerjee RP, Pavesi M, Arroyo V.

J Hepatol. 2016 Jun;64(6):1456-7. doi: 10.1016/j.jhep.2016.01.032. Epub 2016 Feb 2. No abstract available.

PMID:
26836280
42.

Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis.

Artigas A, Wernerman J, Arroyo V, Vincent JL, Levy M.

J Crit Care. 2016 Jun;33:62-70. doi: 10.1016/j.jcrc.2015.12.019. Epub 2015 Dec 29. Review.

PMID:
26831575
43.

Short term effect of air pollution, noise and heat waves on preterm births in Madrid (Spain).

Arroyo V, Díaz J, Ortiz C, Carmona R, Sáez M, Linares C.

Environ Res. 2016 Feb;145:162-168. doi: 10.1016/j.envres.2015.11.034. Epub 2015 Dec 17.

PMID:
26706568
44.

Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis.

Affò S, Rodrigo-Torres D, Blaya D, Morales-Ibanez O, Coll M, Millán C, Altamirano J, Arroyo V, Caballería J, Bataller R, Ginès P, Sancho-Bru P.

PLoS One. 2015 Dec 21;10(12):e0145147. doi: 10.1371/journal.pone.0145147. eCollection 2015.

45.

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).

Grønbæk H, Rødgaard-Hansen S, Aagaard NK, Arroyo V, Moestrup SK, Garcia E, Solà E, Domenicali M, Piano S, Vilstrup H, Møller HJ; CANONIC study investigators of the EASL-CLIF Consortium.

J Hepatol. 2016 Apr;64(4):813-22. doi: 10.1016/j.jhep.2015.11.021. Epub 2015 Nov 27.

PMID:
26639396
46.

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure.

Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, Macnaughtan J, Bendtsen F, Coenraad M, Sperl J, Gines P, Moreau R, Arroyo V, Jalan R; CANONIC Study Investigators of the EASL-CLIF Consortium.

J Hepatol. 2016 Mar;64(3):574-82. doi: 10.1016/j.jhep.2015.10.018. Epub 2015 Oct 28.

PMID:
26519600
47.

Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V.

J Hepatol. 2015 Nov;63(5):1272-84. doi: 10.1016/j.jhep.2015.07.004. Epub 2015 Jul 17. Review.

PMID:
26192220
48.

Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes.

Rodriguez E, Henrique Pereira G, Solà E, Elia C, Barreto R, Pose E, Colmenero J, Fernandez J, Navasa M, Arroyo V, Ginès P.

Liver Transpl. 2015 Nov;21(11):1347-54. doi: 10.1002/lt.24210.

49.

Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.

Ariza X, Solà E, Elia C, Barreto R, Moreira R, Morales-Ruiz M, Graupera I, Rodríguez E, Huelin P, Solé C, Fernández J, Jiménez W, Arroyo V, Ginès P.

PLoS One. 2015 Jun 4;10(6):e0128145. doi: 10.1371/journal.pone.0128145. eCollection 2015.

50.

Acute-on-Chronic Liver Failure: Recent Concepts.

Moreau R, Jalan R, Arroyo V.

J Clin Exp Hepatol. 2015 Mar;5(1):81-5. doi: 10.1016/j.jceh.2014.09.003. Epub 2014 Oct 3. Review.

Supplemental Content

Loading ...
Support Center